AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BOSENTAN

10 registrations across 4 African markets— 7 active

Markets with BOSENTAN

Recent registrations

Brand / ProductMarketHolderStatusExpires
SAFEBO TABLETS🇬🇭GhanaexpiredAug 2026
SAFEBO TABLETS🇬🇭GhanaexpiredAug 2026
PULMOFIRST 125MG COMPRIME BOITE DE 10🇨🇮Côte d'IvoireMSN LABORATORIES PRIVATE LTDexpiredJan 2026
PULMOFIRST 125 CP PELL BTE (1X10) MSN LABORATORIES PRIVATE
Comprimé pelliculé, Boîte de
🇲🇬MadagascarMSN LABORATORIES PRIVATEactive
PULMOFIRST 62,5 CP PELL BTE (1X10) MSN LABORATORIES PRIVATE
Boîte de 1x10
🇲🇬MadagascarMSN LABORATORIES PRIVATEactive
PULMOFIRST 62,5MG COMPRIME BOITE DE 10🇨🇮Côte d'IvoireMSN LABORATORIES PRIVATE LTDactive
PULMOFIRST 125
Tablet, Film-coated
🇹🇿TanzaniaMSN Laboratories Private Limitedactive
PULMOFIRST 62,5 CP PELL BTE (1X10) MSN LABORATORIES PRIVATE
Boîte de 1x10
🇲🇬MadagascarMSN LABORATORIES PRIVATEactive
PULMOFIRST 62.5
Tablet, Film-coated
🇹🇿TanzaniaMSN Laboratories Private Limitedactive
PULMOFIRST 125 CP PELL BTE (1X10) MSN LABORATORIES PRIVATE
Comprimé pelliculé, Boîte de
🇲🇬MadagascarMSN LABORATORIES PRIVATEactive

BOSENTAN in Africa — Regulatory Overview

BOSENTAN is registered across 4 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Côte d'Ivoire, Ghana, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 7 (70%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.